CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 52 enrolled
Drug / intervention
Nucleus Hybrid L24 Implantdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02379819
NCT02379819N/ACompleted
CompareCT.gov

Nucleus Hybrid L24 Implant System: New Enrollment Study

Cochlear·interventional·Posted Mar 5, 2015·Updated Mar 13, 2023

In Brief

A clinical study evaluating Nucleus Hybrid L24 Implant for High Frequency Sensorineural Hearing Loss. Completed, enrolled 52 participants across 19 sites.

Detailed Summary

This study evaluates the long term safety and effectiveness of the Nucleus Hybrid L24 Implant in a group of newly implanted adults.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHigh Frequency Sensorineural Hearing Loss
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 5, 2015
Enrollment StartFeb 1, 2015
Primary CompletionApr 14, 2022
TodayJul 2, 2026
Enrollment to primary: 7.2 yearsPosted 11.3 years ago

Interventions

Nucleus Hybrid L24 Implantdevice